Bluefin Capital Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Bluefin Capital Management, LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$13.17 - $16.4 $167,575 - $208,673
-12,724 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$16.3 - $17.26 $207,401 - $219,616
12,724 New
12,724 $208,000
Q2 2021

Aug 16, 2021
SELL
$16.55 - $18.64 $570,792 - $642,874
-34,489 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$16.71 - $19.9 $576,311 - $686,331
34,489 New
34,489 $630,000

Others Institutions Holding TAK

# of Institutions
337
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email